Companion Diagnostic Development

We Build. We Validate. We Deliver.

ResearchDx integrates and aligns IVD and biopharma development that simplifies, speeds and ensures delivery of your FDA-approved companion diagnostics on time.

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

CompanionDX to Market

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

CompanionDX to Market

No Multi-Partner Outsourcing.

Watch CDO Video

BioPharma Services

Diagnostic resources and expertise to support all phases of FDA drug and companion diagnostic development.

IVD Diagnostics

One-stop shop for IVD diagnostics outsourcing for biopharma, biotechnology, diagnostics companies, clinical laboratories, medical research and physicians.

Clinical Trial Consulting

Full clinical trials program services to support an FDA IVD product filing.

Latest News

trio-smart: The New Breathtaking Technology

PacificDX is the only lab certified to run trio-Smart™, a breath test developed by Gemelli™. Along with measuring the standard H2, CH4 and CO2 levels, trio-smart™ is the only BT that also measures hydrogen sulfide. You are at a fancy dinner party wearing your favorite dress. After the delicious meal, you are conversing with an […]

ResearchDx Partners with Lucid Diagnostics for First DNA Methylation Test for Barrett’s Esophagus

As Lucid Diagnostics’ commercial diagnostic laboratory partner, the new EsoGuard esophageal DNA laboratory-developed test (LDT) was developed and completed CLIA and CAP certification at ResearchDx’s premier molecular laboratory, PacificDx. The first of its kind, this non-invasive DNA test was designed to detect the presence of dysplastic and non-dysplastic Barrett’s Esophagus (BE) and esophageal adenocarcinoma (EAC) […]